Oxford Drug Design attends Fragments 2019

Marco Albanese recently presented a poster on using fragment-based approaches to discover compounds targeting the ATP-binding domain of bacterial histidine kinases at the 7th RSC-BMCS Fragment-based Drug Discovery meeting in Cambridge. Bacterial histidine kinases (HKs) are part of two-component systems (TCSs), the most widespread means by which bacteria sense and adapt to external and internal stimuli.  […]

CARTNET Begins – Oxford Drug Design starts work on AMR training network

Oxford Drug Design has started work on a new €3.4 Million Horizon 2020 Marie Curie European Training Network – CARTNET, “Combating Antimicrobial Resistance Training Network”. CARTNET brings together 13 academic and industrial research groups from 8 countries and will contribute to delivering solutions to the challenges of bacterial infectious diseases that affect both humans and animals. […]

Oxford Drug Design win EU support for antibacterial research

The European Commission has awarded 3.4 Million Euro under the Horizon 2020 programme to a new Marie Curie European Training Network – CARTNET, “Combating Antimicrobial Resistance Training Network”, in which Oxford Drug Design is a consortium partner. CARTNET brings together 13 academic and industrial research groups from 8 countries and will contribute to delivering solutions to […]